{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:10:44Z","timestamp":1793722244616,"version":"4.6.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81571662"],"award-info":[{"award-number":["81571662"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"natural science foundation of zhejiang province","doi-asserted-by":"publisher","award":["LY18H180003"],"award-info":[{"award-number":["LY18H180003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatocellular carcinoma is insensitive to many chemotherapeutic agents. Ferroptosis is a form of programmed cell death with a Fenton reaction mechanism. It converts endogenous hydrogen peroxide into highly toxic hydroxyl radicals, which inhibit hepatocellular carcinoma progression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The morphology, elemental composition, and tumour microenvironment responses of various organic\/inorganic nanoplatforms were characterised by different analytical methods. Their in vivo and in vitro tumour-targeting efficacy and imaging capability were analysed by magnetic resonance imaging. Confocal microscopy, flow cytometry, and western blotting were used to investigate the therapeutic efficacy and mechanisms of complementary ferroptosis\/apoptosis mediated by the nanoplatforms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The nanoplatform consisted of a silica shell doped with iron and disulphide bonds and an etched core loaded with doxorubicin that generates hydrogen peroxide in situ and enhances ferroptosis. It relied upon transferrin for targeted drug delivery and could be activated by the tumour microenvironment. Glutathione-responsive biodegradability could operate synergistically with the therapeutic interaction between doxorubicin and iron and induce tumour cell death through complementary ferroptosis and apoptosis. The nanoplatform also has a superparamagnetic framework that could serve to guide and monitor treatment under T2-weighted magnetic resonance imaging.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This rationally designed nanoplatform is expected to integrate cancer diagnosis, treatment, and monitoring and provide a novel clinical antitumour therapeutic strategy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12951-021-01102-0","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T17:19:45Z","timestamp":1636391985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Self-amplification of oxidative stress with tumour microenvironment-activatable iron-doped nanoplatform for targeting hepatocellular carcinoma synergistic cascade therapy and diagnosis"],"prefix":"10.1186","volume":"19","author":[{"given":"Qiao-Mei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Fei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Ni","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Zhong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0554-9484","authenticated-orcid":false,"given":"Ri-Sheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"issue":"6","key":"1102_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1102_CR2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/COH.0000000000000623","volume":"15","author":"M Maepa","year":"2020","unstructured":"Maepa M, et al. Recent developments with advancing gene therapy to treat chronic infection with hepatitis B virus. Curr Opin HIV AIDS. 2020;15(3):200\u20137.","journal-title":"Curr Opin HIV AIDS"},{"issue":"4","key":"1102_CR3","first-page":"343","volume":"33","author":"S Umeda","year":"2018","unstructured":"Umeda S, Kanda M, Kodera Y. Emerging evidence of molecular biomarkers in hepatocellular carcinoma. Histol Histopathol. 2018;33(4):343\u201355.","journal-title":"Histol Histopathol"},{"issue":"7","key":"1102_CR4","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.3390\/ijms22073315","volume":"22","author":"ACK Lee","year":"2021","unstructured":"Lee ACK, et al. Mitochondrial fuel dependence on glutamine drives chemo-resistance in the cancer stem cells of hepatocellular carcinoma. Int J Mol Sci. 2021;22(7):3315.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1102_CR5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"1102_CR6","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jhep.2011.07.031","volume":"56","author":"U Asghar","year":"2012","unstructured":"Asghar U, Meyer T. Are there opportunities for chemotherapy in the treatment of hepatocellular cancer? J Hepatol. 2012;56(3):686\u201395.","journal-title":"J Hepatol"},{"issue":"12","key":"1102_CR7","doi-asserted-by":"crossref","first-page":"12380","DOI":"10.1021\/acsnano.8b06399","volume":"12","author":"S Wang","year":"2018","unstructured":"Wang S, et al. Arginine-rich manganese silicate nanobubbles as a ferroptosis-inducing agent for tumor-targeted theranostics. ACS Nano. 2018;12(12):12380\u201392.","journal-title":"ACS Nano"},{"issue":"36","key":"1102_CR8","doi-asserted-by":"crossref","first-page":"e2002246","DOI":"10.1002\/adma.202002246","volume":"32","author":"X Lu","year":"2020","unstructured":"Lu X, et al. Bioinspired copper single-atom catalysts for tumor parallel catalytic therapy. Adv Mater (Deerfield Beach, Fla). 2020;32(36):e2002246.","journal-title":"Adv Mater (Deerfield Beach, Fla)"},{"issue":"25","key":"1102_CR9","doi-asserted-by":"crossref","first-page":"9937","DOI":"10.1021\/jacs.9b03457","volume":"141","author":"LS Lin","year":"2019","unstructured":"Lin LS, et al. Synthesis of copper peroxide nanodots for H(2)O(2) self-supplying chemodynamic therapy. J Am Chem Soc. 2019;141(25):9937\u201345.","journal-title":"J Am Chem Soc"},{"key":"1102_CR10","doi-asserted-by":"crossref","first-page":"120262","DOI":"10.1016\/j.biomaterials.2020.120262","volume":"257","author":"M Xiao","year":"2020","unstructured":"Xiao M, et al. A photosensitizer-inhibitor conjugate for photodynamic therapy with simultaneous inhibition of treatment escape pathways. Biomaterials. 2020;257:120262.","journal-title":"Biomaterials"},{"issue":"11","key":"1102_CR11","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1039\/D1BM00198A","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. Oxygen-carrying nanoparticle-based chemo-sonodynamic therapy for tumor suppression and autoimmunity activation. Biomater Sci. 2021;9(11):3989\u20134004.","journal-title":"Biomater Sci"},{"issue":"7664","key":"1102_CR12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"V Viswanathan","year":"2017","unstructured":"Viswanathan V, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547(7664):453\u20137.","journal-title":"Nature"},{"issue":"21","key":"1102_CR13","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.7150\/thno.36283","volume":"9","author":"M Sang","year":"2019","unstructured":"Sang M, et al. Mitochondrial membrane anchored photosensitive nano-device for lipid hydroperoxides burst and inducing ferroptosis to surmount therapy-resistant cancer. Theranostics. 2019;9(21):6209\u201323.","journal-title":"Theranostics"},{"issue":"11","key":"1102_CR14","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1021\/jacs.9b12873","volume":"142","author":"Y Sang","year":"2020","unstructured":"Sang Y, et al. Bioinspired construction of a nanozyme-based HO homeostasis disruptor for intensive chemodynamic therapy. J Am Chem Soc. 2020;142(11):5177\u201383.","journal-title":"J Am Chem Soc"},{"issue":"4","key":"1102_CR15","doi-asserted-by":"crossref","first-page":"7774","DOI":"10.1021\/acsnano.1c01830","volume":"15","author":"D Jana","year":"2021","unstructured":"Jana D, et al. Ultrasmall alloy nanozyme for ultrasound- and near-infrared light-promoted tumor ablation. ACS Nano. 2021;15(4):7774\u201382.","journal-title":"ACS Nano"},{"key":"1102_CR16","doi-asserted-by":"crossref","first-page":"120710","DOI":"10.1016\/j.biomaterials.2021.120710","volume":"271","author":"L Deng","year":"2021","unstructured":"Deng L, et al. Low-intensity focused ultrasound-augmented Cascade chemodynamic therapy via boosting ROS generation. Biomaterials. 2021;271:120710.","journal-title":"Biomaterials"},{"issue":"9","key":"1102_CR17","doi-asserted-by":"crossref","first-page":"e2002126","DOI":"10.1002\/adhm.202002126","volume":"10","author":"H Zhou","year":"2021","unstructured":"Zhou H, et al. Ultrasensitive chemodynamic therapy: bimetallic peroxide triggers high pH-activated, synergistic effect\/H O self-supply-mediated cascade fenton chemistry. Adv Healthc Mater. 2021;10(9):e2002126.","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"1102_CR18","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1021\/acsnano.5b06175","volume":"10","author":"WP Li","year":"2016","unstructured":"Li WP, et al. Ultrasound-induced reactive oxygen species mediated therapy and imaging using a fenton reaction activable polymersome. ACS Nano. 2016;10(2):2017\u201327.","journal-title":"ACS Nano"},{"key":"1102_CR19","doi-asserted-by":"crossref","first-page":"119568","DOI":"10.1016\/j.biomaterials.2019.119568","volume":"228","author":"Y Hao","year":"2020","unstructured":"Hao Y, et al. Near-infrared light and glucose dual-responsive cascading hydroxyl radical generation for in situ gelation and effective breast cancer treatment. Biomaterials. 2020;228:119568.","journal-title":"Biomaterials"},{"issue":"21","key":"1102_CR20","doi-asserted-by":"crossref","first-page":"9570","DOI":"10.1039\/D1NR02159A","volume":"13","author":"L Yue","year":"2021","unstructured":"Yue L, et al. Supramolecular nanovesicles for synergistic glucose starvation and hypoxia-activated gene therapy of cancer. Nanoscale. 2021;13(21):9570\u20136.","journal-title":"Nanoscale"},{"issue":"7","key":"1102_CR21","doi-asserted-by":"crossref","first-page":"e2006892","DOI":"10.1002\/adma.202006892","volume":"33","author":"L Fu","year":"2021","unstructured":"Fu L, et al. Nanocatalytic theranostics with glutathione depletion and enhanced reactive oxygen species generation for efficient cancer therapy. Adv Mater (Deerfield Beach, Fla). 2021;33(7):e2006892.","journal-title":"Adv Mater (Deerfield Beach, Fla)"},{"key":"1102_CR22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jcis.2021.03.173","volume":"599","author":"L Zhang","year":"2021","unstructured":"Zhang L, et al. One-pot synthesis of a self-reinforcing cascade bioreactor for combined photodynamic\/chemodynamic\/starvation therapy. J Colloid Interface Sci. 2021;599:543\u201355.","journal-title":"J Colloid Interface Sci"},{"key":"1102_CR23","doi-asserted-by":"crossref","first-page":"120429","DOI":"10.1016\/j.biomaterials.2020.120429","volume":"266","author":"J Zhang","year":"2021","unstructured":"Zhang J, et al. Heparanase-driven sequential released nanoparticles for ferroptosis and tumor microenvironment modulations synergism in breast cancer therapy. Biomaterials. 2021;266:120429.","journal-title":"Biomaterials"},{"key":"1102_CR24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2021.04.007","volume":"333","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Ferrocene-containing polymersome nanoreactors for synergistically amplified tumor-specific chemodynamic therapy. J Control Release. 2021;333:500\u201310.","journal-title":"J Control Release"},{"key":"1102_CR25","doi-asserted-by":"crossref","first-page":"120739","DOI":"10.1016\/j.biomaterials.2021.120739","volume":"271","author":"Y Yang","year":"2021","unstructured":"Yang Y, et al. Blue light-triggered Fe-release from monodispersed ferrihydrite nanoparticles for cancer iron therapy. Biomaterials. 2021;271:120739.","journal-title":"Biomaterials"},{"issue":"1","key":"1102_CR26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"V Kagan","year":"2017","unstructured":"Kagan V, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13(1):81\u201390.","journal-title":"Nat Chem Biol"},{"issue":"4","key":"1102_CR27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41589-020-00734-x","volume":"17","author":"W Sun","year":"2021","unstructured":"Sun W, et al. Phospholipase iPLA\u03b2 averts ferroptosis by eliminating a redox lipid death signal. Nat Chem Biol. 2021;17(4):465\u201376.","journal-title":"Nat Chem Biol"},{"issue":"6","key":"1102_CR28","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Berghe TV. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35(6):830\u201349.","journal-title":"Cancer Cell"},{"issue":"1","key":"1102_CR29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drudis.2019.09.017","volume":"25","author":"M Norouzi","year":"2020","unstructured":"Norouzi M, et al. Clinical applications of nanomedicine in cancer therapy. Drug Discovery Today. 2020;25(1):107\u201325.","journal-title":"Drug Discovery Today"},{"issue":"16","key":"1102_CR30","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1021\/jacs.0c10098","volume":"143","author":"F Lin","year":"2021","unstructured":"Lin F, et al. Magnetism, ultrasound, and light-stimulated mesoporous silica nanocarriers for theranostics and beyond. J Am Chem Soc. 2021;143(16):6025\u201336.","journal-title":"J Am Chem Soc"},{"issue":"25","key":"1102_CR31","doi-asserted-by":"crossref","first-page":"e2007073","DOI":"10.1002\/adma.202007073","volume":"33","author":"Q Wu","year":"2021","unstructured":"Wu Q, et al. Surface wettability of nanoparticle modulated sonothrombolysis. Adv Mater (Deerfield Beach, Fla). 2021;33(25):e2007073.","journal-title":"Adv Mater (Deerfield Beach, Fla)"},{"key":"1102_CR32","doi-asserted-by":"crossref","first-page":"113372","DOI":"10.1016\/j.ejmech.2021.113372","volume":"217","author":"Y Fu","year":"2021","unstructured":"Fu Y, et al. Poly ethylene glycol (PEG)-Related controllable and sustainable antidiabetic drug delivery systems. Eur J Med Chem. 2021;217:113372.","journal-title":"Eur J Med Chem"},{"key":"1102_CR33","doi-asserted-by":"crossref","first-page":"122402","DOI":"10.1016\/j.talanta.2021.122402","volume":"231","author":"R Jin","year":"2021","unstructured":"Jin R, et al. Pollen-like silica nanoparticles as a nanocarrier for tumor targeted and pH-responsive drug delivery. Talanta. 2021;231:122402.","journal-title":"Talanta"},{"issue":"23","key":"1102_CR34","doi-asserted-by":"crossref","first-page":"e2100820","DOI":"10.1002\/adma.202100820","volume":"33","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, et al. General synthesis of ultrafine monodispersed hybrid nanoparticles from highly stable monomicelles. Adv Mater (Deerfield Beach, Fla). 2021;33(23):e2100820.","journal-title":"Adv Mater (Deerfield Beach, Fla)"},{"issue":"1","key":"1102_CR35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12951-020-00653-y","volume":"18","author":"W Guo","year":"2020","unstructured":"Guo W, et al. Biodegradable hollow mesoporous organosilica nanotheranostics (HMON) for multi-mode imaging and mild photo-therapeutic-induced mitochondrial damage on gastric cancer. J Nanobiotechnology. 2020;18(1):99.","journal-title":"J Nanobiotechnology"},{"key":"1102_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.02.018","volume":"163","author":"L Wang","year":"2018","unstructured":"Wang L, et al. Iron-engineered mesoporous silica nanocatalyst with biodegradable and catalytic framework for tumor-specific therapy. Biomaterials. 2018;163:1\u201313.","journal-title":"Biomaterials"},{"issue":"9","key":"1102_CR37","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1039\/D0NR08757B","volume":"13","author":"Q Chen","year":"2021","unstructured":"Chen Q, et al. Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment. Nanoscale. 2021;13(9):4855\u201370.","journal-title":"Nanoscale"},{"issue":"9","key":"1102_CR38","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.3390\/ijms22094591","volume":"22","author":"A Vogt","year":"2021","unstructured":"Vogt A, et al. On Iron metabolism and its regulation. Int J Mol Sci. 2021;22(9):4591.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1102_CR39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12951-021-00777-9","volume":"19","author":"K Wang","year":"2021","unstructured":"Wang K, et al. Protein liposomes-mediated targeted acetylcholinesterase gene delivery for effective liver cancer therapy. J Nanobiotechnology. 2021;19(1):31.","journal-title":"J Nanobiotechnology"},{"issue":"8","key":"1102_CR40","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1039\/C9BM02036E","volume":"8","author":"Y Cai","year":"2020","unstructured":"Cai Y, et al. Tumor-targeting peptide functionalized PEG-PLA micelles for efficient drug delivery. Biomater Sci. 2020;8(8):2274\u201382.","journal-title":"Biomater Sci"},{"key":"1102_CR41","doi-asserted-by":"crossref","first-page":"120457","DOI":"10.1016\/j.biomaterials.2020.120457","volume":"266","author":"J Chen","year":"2021","unstructured":"Chen J, et al. A redox-triggered C-centered free radicals nanogenerator for self-enhanced magnetic resonance imaging and chemodynamic therapy. Biomaterials. 2021;266:120457.","journal-title":"Biomaterials"},{"issue":"17","key":"1102_CR42","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1002\/adma.201505147","volume":"28","author":"Y Chen","year":"2016","unstructured":"Chen Y, Shi J. Chemistry of mesoporous organosilica in nanotechnology: molecularly organic-inorganic hybridization into frameworks. Adv Mater. 2016;28(17):3235\u201372.","journal-title":"Adv Mater"},{"issue":"4","key":"1102_CR43","doi-asserted-by":"crossref","first-page":"1907716","DOI":"10.1002\/adfm.201907716","volume":"30","author":"L Li","year":"2020","unstructured":"Li L, et al. In situ polymerized hollow mesoporous organosilica biocatalysis nanoreactor for enhancing ROS-mediated anticancer therapy. Adv Funct Mater. 2020;30(4):1907716.","journal-title":"Adv Funct Mater"},{"issue":"22","key":"1102_CR44","doi-asserted-by":"crossref","first-page":"1700720","DOI":"10.1002\/adhm.201700720","volume":"6","author":"L Wang","year":"2017","unstructured":"Wang L, et al. Coordination-accelerated \u201ciron extraction\u201d enables fast biodegradation of mesoporous silica-based hollow nanoparticles. Adv Healthc Mater. 2017;6(22):1700720.","journal-title":"Adv Healthc Mater"},{"issue":"45","key":"1102_CR45","doi-asserted-by":"crossref","first-page":"e2001805","DOI":"10.1002\/smll.202001805","volume":"16","author":"H Wu","year":"2020","unstructured":"Wu H, et al. Smart porous core-shell cuprous oxide nanocatalyst with high biocompatibility for acid-triggered chemo\/chemodynamic synergistic therapy. Small. 2020;16(45):e2001805.","journal-title":"Small"},{"issue":"1","key":"1102_CR46","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/s41467-019-09158-1","volume":"10","author":"W Fan","year":"2019","unstructured":"Fan W, et al. Generic synthesis of small-sized hollow mesoporous organosilica nanoparticles for oxygen-independent X-ray-activated synergistic therapy. Nat Commun. 2019;10(1):1241.","journal-title":"Nat Commun"},{"issue":"46","key":"1102_CR47","doi-asserted-by":"crossref","first-page":"e2001343","DOI":"10.1002\/smll.202001343","volume":"16","author":"T Jia","year":"2020","unstructured":"Jia T, et al. Intelligent Fe-Mn layered double hydroxides nanosheets anchored with upconversion nanoparticles for oxygen-elevated synergetic therapy and bioimaging. Small. 2020;16(46):e2001343.","journal-title":"Small"},{"key":"1102_CR48","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.2147\/IJN.S257628","volume":"15","author":"J Zhou","year":"2020","unstructured":"Zhou J, et al. Dual-effect of magnetic resonance imaging reporter gene in diagnosis and treatment of hepatocellular carcinoma. Int J Nanomed. 2020;15:7235\u201349.","journal-title":"Int J Nanomed"},{"issue":"4","key":"1102_CR49","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1021\/acsami.0c20268","volume":"13","author":"Q Chen","year":"2021","unstructured":"Chen Q, et al. Tumor microenvironment-responsive nanococktails for synergistic enhancement of cancer treatment via cascade reactions. ACS Appl Mater Interfaces. 2021;13(4):4861\u201373.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"1102_CR50","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3390\/cells10082163","volume":"10","author":"NC Ferreira Junior","year":"2021","unstructured":"Ferreira Junior NC, et al. The chemically-modified tetracycline COL-3 and its parent compound doxycycline prevent microglial inflammatory responses by reducing glucose-mediated oxidative stress. Cells. 2021;10(8):2163.","journal-title":"Cells"},{"key":"1102_CR51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jare.2021.02.004","volume":"33","author":"H Veroniaina","year":"2021","unstructured":"Veroniaina H, Wu Z, Qi X. Innate tumor-targeted nanozyme overcoming tumor hypoxia for cancer theranostic use. J Adv Res. 2021;33:201\u201313.","journal-title":"J Adv Res"},{"key":"1102_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-021-01495-6","author":"D Li","year":"2021","unstructured":"Li D, Zhang M, Chao H. Significance of glutathione peroxidase 4 and intracellular iron level in ovarian cancer cells-\"utilization\" of ferroptosis mechanism. Inflamm Res. 2021. https:\/\/doi.org\/10.1007\/s00011-021-01495-6.","journal-title":"Inflamm Res"},{"issue":"2","key":"1102_CR53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","volume":"65","author":"O Tacar","year":"2013","unstructured":"Tacar O, Sriamornsak P, Dass C. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol. 2013;65(2):157\u201370.","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"1102_CR54","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/jcmm.13008","volume":"21","author":"H Yu","year":"2017","unstructured":"Yu H, et al. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J Cell Mol Med. 2017;21(4):648\u201357.","journal-title":"J Cell Mol Med"},{"issue":"14","key":"1102_CR55","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.3390\/ijms21144908","volume":"21","author":"MM Capelletti","year":"2020","unstructured":"Capelletti MM, et al. Ferroptosis in liver diseases: an overview. Int J Mol Sci. 2020;21(14):4908.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1102_CR56","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang X, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci USA. 2019;116(7):2672\u201380.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-021-01102-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-021-01102-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-021-01102-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T17:28:49Z","timestamp":1636392529000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-021-01102-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1102"],"URL":"https:\/\/doi.org\/10.1186\/s12951-021-01102-0","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"assertion":[{"value":"3 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the animal experiments were in line with the ARRIVE guidelines and were carried out according to the National Institutes of Health (NIH, USA) protocols, approved by the guidelines of the Ethical Committee of the Second Affiliated Hospital Zhejiang University School of Medicine (No.2021\u2013104).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to submit this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"361"}}